Skip to content

Clinical trials

Neurocognitive Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20161
20181
20201
20211
20223
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed3
Unknown status3
Not yet recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Academy of Medical Sciences, Fuwai Hospital3
Eli Lilly and Company1
First Affiliated Hospital of Wannan Medical College1
Fujian Provincial Hospital1
Henan Provincial People's Hospital1
Peking University First Hospital1
Ruijin Hospital1
Second Affiliated Hospital of Wenzhou Medical University1
Sinotau Pharmaceutical Group1
Tianjin First Central Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders15
Alzheimer Disease4
Cognitive Dysfunction4
Mental Disorders4
Brain Diseases3
Central Nervous System Diseases3
Dementia3
Nervous System Diseases3
Neurodegenerative Diseases3
Plaque, Amyloid2

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.